Mergers & Acquisitions

CSL Logo

CSL

Communications advisor for various acquisitions and proposals including:

US $275 million purchase of the Novartis

Talecris Biotherapeutics

US $925 million acquisition of Aventis Behring

$108 million Zenyth Therapeutics acquisition

Disposal of CSL Animal Health unit to Pfizer